SYMPATHO-ADRENAL SYSTEM IN ARTERIAL HYPERTENSION PATIENTS: ACTIVITY ASSESSMENT AND CLINICAL VALUE
Abstract
The study was focused on assessing sympatho-adrenal system (SAS) activity in patients with arterial hypertension and included 454 hypertensive individuals at high risk. Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were measured by radio-immune method. Adrenalin and noradrenalin concentration in 24-hour urine was measured by fluorometry. SAS increase was associated with increased PRA and decreased PAC or PAC/PRA ratio. On the contrary, SAS reduction was linked to decreased PRA and elevated PAC or PAC/PRA ratio. Heart rate at rest electrocardiography correlated with 24-hour urine excretion of catecholamines.
About the Authors
Sh. V. Akhadov
Городская поликлиника № 81 УЗ САО
Russian Federation
Russian Federation
G. R. Ruzbanova
Городская поликлиника № 81 УЗ САО
Russian Federation
Russian Federation
G. S. Molchanova
Московский областной научно-исследовательский клинический институт им. М.Ф.Владимирского, Москва
Russian Federation
Russian Federation
T. G. Talalaeva
Московский областной научно-исследовательский клинический институт им. М.Ф.Владимирского, Москва
Russian Federation
Russian Federation
S. N. Khoreva
Московский областной научно-исследовательский клинический институт им. М.Ф.Владимирского, Москва
Russian Federation
Russian Federation
References
1. European guidelines on cardiovascular disease prevention in clinical practice: executive summary Fourth Ioint Task Force of the European Society of Cardiovascular Disease Prevention in Clinical Practice // Euro Heat J. On line, 28 August 2007.
2. Fogari R, Zoppi A, Malamini GD. et al. Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetics. Prevalense of impaired diurnal blood pressure patterns// Am. J. Hypertens 1993; 6; 1–7.
3. Janssen I, Katzmarzyk P, Church TS. et al. The Cooper Clinic Mortality Risk Index. Clinical Score Sheet for Men// Am. J, Prev Med 2005; 29;194–203.
4. Sanjuliani A.F., V.Genelhu de Abreu, J. Ueleres Braga et al. Влияние моксонидина на симпатическую нервную систему артериальное давление, активность ренина плазмы, альдостерон плазмы, лептин и метаболический профиль препарата у больных артериальной гипертонией с ожирением// Обзоры клинической кардиологии. 2006, № 7, стр.48–59.
5. Simon G, Illyes G. Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, and sympathetic stimulation, alone and in combination in rats// Hypertension 2001; 37:255–60.
6. The BEAUTIFUL Study Group. The BEAUTIFUL Study/ Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Desease and Left Ventricular Dysfuntion- Baseline Characteristics of the Study Population Cardiology// Cardiology 2008;110;271–282.
7. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology; 2007 Guidelines for the management of arterial hypertension// J Hypertens 2007; 1105–87
Review
For citations:
Akhadov Sh.V., Ruzbanova G.R., Molchanova G.S., Talalaeva T.G., Khoreva S.N. SYMPATHO-ADRENAL SYSTEM IN ARTERIAL HYPERTENSION PATIENTS: ACTIVITY ASSESSMENT AND CLINICAL VALUE. Russian Journal of Cardiology. 2009;(2):13-17. (In Russ.)
Views:
322
Email this article 